is tirzepatide safe for hypothyroidism with Hypothyroidism: Weight Loss Guide is tirzepatide safe for hypothyroidism

European Journal of Medical Research, 27(1), 1-6

As female-physiology body composition research has matured, two compounds have emerged as the dominant reference points for investigating visceral fat specifically: Tesamorelin, a stabilized Growth Hormone Releasing Hormone (GHRH) analog with a uniquely well-documented visceral-fat research profile, and Retatrutide, an engineered triple agonist peptide studied for aggressive, multi-pathway metabolic effects

Using all three approved sites spreads the injection load across maximum available tissue, reducing the risk of localized problems at any single site

Any weight loss resulting from the medication is a bonus for patients